|
Please note that this page does not hosts or makes available any of the listed filenames. You
cannot download any of those files from here.
|
| 01.01 Autonomic Nervous System (ANS) Overview.mp4 |
37.92MB |
| 01.01 Insulin – Diabetes Medications.mp4 |
19.07MB |
| 01.01 Introduction to High Blood Pressure Medication – Drugs in Hypertension.mp4 |
9.76MB |
| 01.01 Introduction to Kinetics Pharmacokinetics (PK).mp4 |
32.04MB |
| 01.01 Overview – Cell Wall Synthesis Inhibitors (Antibiotics).mp4 |
6.90MB |
| 01.01 Overview of Sedative and Hypnotic Drugs – Sedative Hypnotics.mp4 |
51.63MB |
| 01.02 Benzodiazepines – Sedative Hypnotics.mp4 |
33.35MB |
| 01.02 Diuretics – Drugs in Hypertension.mp4 |
56.44MB |
| 01.02 Dual Innervation.mp4 |
23.14MB |
| 01.02 Hydrophilic vs. Hydrophobic – Absorption and Distribution Pharmacokinetics (PK).mp4 |
27.02MB |
| 01.02 Insulin Types & Glycemic Excursions – Diabetes Medications.mp4 |
25.11MB |
| 01.02 Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics).mp4 |
30.16MB |
| 01.03 Alpha- and Beta-Blockers.mp4 |
30.18MB |
| 01.03 Barbiturates – Sedative Hypnotics.mp4 |
12.75MB |
| 01.03 Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics).mp4 |
20.16MB |
| 01.03 pKa and Drug Solubility – Absorption and Distribution Pharmacokinetics (PK).mp4 |
36.57MB |
| 01.03 Renin Angiotensin Aldosterone – Drugs in Hypertension.mp4 |
58.57MB |
| 01.03 Secretagogues and Biguanides – Diabetes Medications.mp4 |
27.98MB |
| 01.04 Atypical Antipsychotic Drugs – Sedative Hypnotics.mp4 |
54.38MB |
| 01.04 Carbapenems – Cell Wall Synthesis Inhibitors (Antibiotics).mp4 |
6.95MB |
| 01.04 Drug Distribution – Absorption and Distribution Pharmacokinetics (PK).mp4 |
36.55MB |
| 01.04 Metformin, Alpha Glucosidase Inhibitors and Thiazolidinediones – Diabetes Medications.mp4 |
40.04MB |
| 01.04 Sympathetic Blockers.mp4 |
28.71MB |
| 01.04 Vasodilators – Drugs in Hypertension.mp4 |
48.10MB |
| 01.05 Alpha Blockers – Drugs in Hypertension.mp4 |
11.74MB |
| 01.05 DPP-4 Inhibitors and GLP-1 Analogues – Diabetes Medications.mp4 |
28.04MB |
| 01.05 Phases of Drug Development – Absorption and Distribution Pharmacokinetics (PK).mp4 |
38.58MB |
| 01.05 Questions – Sedative Hypnotics.mp4 |
15.52MB |
| 01.05 Vancomycin, Bacitracin and Daptomycin – Cell Wall Synthesis Inhibitors (Antibiotics).mp4 |
19.69MB |
| 01.06 Beta Blockers – Drugs in Hypertension.mp4 |
29.15MB |
| 01.06 Case Study – Sedative Hypnotics.mp4 |
21.39MB |
| 01.06 Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4 |
33.48MB |
| 01.06 SGLT2 Inhibitors – Diabetes Medications.mp4 |
50.16MB |
| 01.07 Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4 |
30.75MB |
| 01.07 Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension.mp4 |
13.39MB |
| 01.07 Questions – Diabetes Medications.mp4 |
59.92MB |
| 01.08 Lines of Therapy – Drugs in Hypertension.mp4 |
47.59MB |
| 01.08 Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4 |
24.42MB |
| 01.09 Pulmonary Hypertension Medication – Drugs in Hypertension.mp4 |
16.51MB |
| 01.09 Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4 |
23.32MB |
| 01.10 Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4 |
36.91MB |
| 01.10 Questions and Case Studies – Drugs in Hypertension.mp4 |
33.77MB |
| 01.11 Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics).mp4 |
47.83MB |
| 01. Asthma Medications.mp4 |
14.35MB |
| 01. Overview Coagulant Drugs.mp4 |
5.71MB |
| 01. Overview – Reproductive Pharmacology.mp4 |
10.31MB |
| 01. Pharmacology of Inflammation.mp4 |
47.98MB |
| 01. Questions and Case Studies Steroids, Cyclosprine and Crohn's Disease.mp4 |
45.75MB |
| 02.01 Cholinomimetic Activators.mp4 |
19.25MB |
| 02.01 Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4 |
49.38MB |
| 02.01 Introduction – Angina and Heart Failure Management.mp4 |
15.62MB |
| 02.01 Overview – Adrenal Pharmacology.mp4 |
4.22MB |
| 02.01 Overview – Antidepressants.mp4 |
14.49MB |
| 02.01 Overview – Antimetabolites.mp4 |
5.57MB |
| 02.02 Cholinomimetic Effects.mp4 |
37.52MB |
| 02.02 Factors Affecting Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4 |
108.04MB |
| 02.02 Mineralocorticoids and Glucocorticoids – Adrenal Pharmacology.mp4 |
49.80MB |
| 02.02 Monoamine Oxidase Inhibitors (MAOIs) – Antidepressants.mp4 |
23.58MB |
| 02.02 Nitrates – Angina and Heart Failure Management.mp4 |
28.34MB |
| 02.02 Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites.mp4 |
56.70MB |
| 02.03 Cardiac Depressants, Metabolic Modifiers and Slow Sodium Channel Inhibitors – Angina and Heart Failure Management.mp4 |
21.11MB |
| 02.03 Case Studies – Antimetabolites.mp4 |
22.13MB |
| 02.03 Catecholamines – Adrenal Pharmacology.mp4 |
19.21MB |
| 02.03 Special Topic Cholinergic Toxicity, Poisoning, Myestenia Crisis and Cholinergic Crisis.mp4 |
36.87MB |
| 02.03 Tricyclic Antidepressants (TCAs) – Antidepressants.mp4 |
23.12MB |
| 02.04 Heterocyclic Antidepressants – Antidepressants.mp4 |
14.30MB |
| 02.04 Inotropes – Angina and Heart Failure Management.mp4 |
37.25MB |
| 02.04 Overview – Antimycobacterial Agents.mp4 |
6.48MB |
| 02.04 Questions and Case Studies – Adrenal Pharmacology.mp4 |
22.57MB |
| 02.05 Antituberculosis Drugs – Antimycobacterial Agents.mp4 |
41.65MB |
| 02.05 SNRIs, Serotonin Antagonists and SSRIs – Antidepressants.mp4 |
52.57MB |
| 02.05 Vasodilators – Angina and Heart Failure Management.mp4 |
18.01MB |
| 02.06 Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management.mp4 |
15.14MB |
| 02.06 Review – Antidepressants.mp4 |
7.24MB |
| 02.06 Treatment Regimens for Mycobacterium Tuberculosis, Leprosy and Other Infections – Antimycobacterial Agents.mp4 |
24.91MB |
| 02.07 Case Studies – Antimycobacterial Agents.mp4 |
38.87MB |
| 02.07 Questions – Angina and Heart Failure Management.mp4 |
39.23MB |
| 02.07 Questions – Antidepressants.mp4 |
22.77MB |
| 02. Acetylsalicylic Acid (ASA).mp4 |
31.37MB |
| 02. Antiplatelets.mp4 |
44.48MB |
| 02. Bronchodilators.mp4 |
21.59MB |
| 02. Estrogens and Progestins – Reproductive Pharmacology.mp4 |
66.52MB |
| 02 Inflammatory Bowel Disease Medication.mp4 |
76.62MB |
| 03.01 Introduction and Definitions of Pharmacodynamics – Pharmacodynamics.mp4 |
16.09MB |
| 03.01 Introduction – Antiarrhythmic Drugs.mp4 |
4.45MB |
| 03.01 Overview – Antifungals.mp4 |
4.88MB |
| 03.01 Overview – Antipsychotics.mp4 |
9.09MB |
| 03.01 Sympathomimetic Activators.mp4 |
30.33MB |
| 03.02 Azoles – Antifungals.mp4 |
30.32MB |
| 03.02 Drug Receptors and Effectors – Pharmacodynamics.mp4 |
17.01MB |
| 03.02 Effects of Increasing Dopamine – Antipsychotics.mp4 |
14.06MB |
| 03.02 Group 1 Sodium Channel Blockers – Antiarrhythmic Drugs.mp4 |
32.74MB |
| 03.02 Sympathomimetic Effects.mp4 |
79.06MB |
| 03.03 Bipolar Disorder Medication – Antipsychotics.mp4 |
31.30MB |
| 03.03 Global Effect of Sympathomimetic Drugs on the Vascular System.mp4 |
37.12MB |
| 03.03 Group 2 Beta Blockers – Antiarrhythmic Drugs.mp4 |
11.81MB |
| 03.03 Polyenes – Antifungals.mp4 |
30.99MB |
| 03.03 Upregulation and Downregulation – Pharmacodynamics.mp4 |
5.39MB |
| 03.04 Anticholinergic Drugs.mp4 |
57.09MB |
| 03.04 Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics.mp4 |
72.49MB |
| 03.04 Flucytosine (5-Fluorocytosine5-FU) – Antifungals.mp4 |
10.02MB |
| 03.04 Group 3 Potassium Channel Blockers – Antiarrhythmic Drugs.mp4 |
23.91MB |
| 03.04 Psychotic Disorder Medication – Antipsychotics.mp4 |
21.14MB |
| 03.05 Clinical Uses of Antipsychotics and Drug Induced Dyskinesia.mp4 |
24.68MB |
| 03.05 Echinocandins and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals.mp4 |
13.45MB |
| 03.05 Group 4 Calcium Channel Blockers – Antiarrhythmic Drugs.mp4 |
12.02MB |
| 03.05 Toxicology Questions & Case Studies.mp4 |
55.24MB |
| 03.06 Group 5 Other Antiarrhythmics – Antiarrhythmic Drugs.mp4 |
24.87MB |
| 03.06 Questions – Antifungals.mp4 |
18.86MB |
| 03.06 Questions – Antipsychotics.mp4 |
15.96MB |
| 03.07 Questions – Antiarrhythmic Drugs.mp4 |
21.42MB |
| 03. Anticoagulants.mp4 |
69.01MB |
| 03. Anti-Estrogens and Antiprogestins – Reproductive Pharmacology.mp4 |
41.68MB |
| 03. Corticosteroids.mp4 |
14.40MB |
| 03. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).mp4 |
20.60MB |
| 03. Stomach Ulcer (Peptic Acid Disease) Medication.mp4 |
51.20MB |
| 04.01 Dopamine Hypothesis – Medication of Movement Disorders.mp4 |
19.82MB |
| 04.01 Introduction Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control.mp4 |
40.71MB |
| 04.01 Introduction esp. Types of Eliminations – Elimination Kinetics.mp4 |
22.54MB |
| 04.01 Overview – Antiviral Drugs.mp4 |
16.95MB |
| 04.02 Anti-HIV Agents Fusion Inhibitors – Antiviral Drugs.mp4 |
9.62MB |
| 04.02 Dopamine Precursors and Agonists – Treatment of Movement Disorders.mp4 |
46.57MB |
| 04.02 First Pass Metabolism – Elimination Kinetics.mp4 |
13.43MB |
| 04.02 HMG-CoA Reductase Inhibitors – Lipid Control.mp4 |
63.37MB |
| 04.03 Anti-HIV Agents Nucleoside Reverse Transcriptase Inhibitors (NRTI) – Antiviral Drugs.mp4 |
57.30MB |
| 04.03 Bioavailability incl. Case Study – Elimination Kinetics.mp4 |
15.10MB |
| 04.03 Fat Absorption and MTP Inhibitors – Lipid Control.mp4 |
24.28MB |
| 04.03 MAO and COMT Inhibitors – Treatment of Movement Disorders.mp4 |
21.99MB |
| 04.04 Amantadine and Anticholinergics – Medication of Movement Disorders.mp4 |
16.48MB |
| 04.04 Anti-HIV Agents Reverse Transcriptase Inhibitors (NNRTI) – Antiviral Drugs.mp4 |
31.61MB |
| 04.04 Dosage Calculation Maintenance Dose and Loading Dose – Elimination Kinetics.mp4 |
35.64MB |
| 04.04 PCSK9 Inhibitors – Lipid Control.mp4 |
55.59MB |
| 04.05 Anti-HIV Agents Integrase Strand Transfer Inhibitors – Antiviral Drugs.mp4 |
15.16MB |
| 04.05 Intravenous vs. Oral Medications – Elimination Kinetics.mp4 |
8.71MB |
| 04.05 Postural Tremor, Huntington's Disease, Tourette's Syndrome, Wilsons's Disease and Drug Induced Dyskinesia – Medication of Movement Dis.mp4 |
35.00MB |
| 04.05 Questions – Lipid Control.mp4 |
18.96MB |
| 04.06 Anti-HIV Agents Protease Inhibitors – Antiviral Drugs.mp4 |
49.02MB |
| 04.06 Renal Clearance – Elimination Kinetics.mp4 |
32.69MB |
| 04.07 Anti-HIV Agents CCR5 Antagonist – Antiviral Drugs.mp4 |
14.46MB |
| 04.08 Questions about Anti-HIV Agents – Antiviral Drugs.mp4 |
13.84MB |
| 04.09 Case Studies about Anti-HIV Agents – Antiviral Drugs.mp4 |
15.78MB |
| 04.10 Anti-Herpes Agents Thymidine Kinase Agents – Antiviral Drugs.mp4 |
35.04MB |
| 04.11 Anti-Herpes Agents RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs.mp4 |
23.04MB |
| 04.12 Influenza Treatment – Antiviral Drugs.mp4 |
15.35MB |
| 04.13 Hepatitis Treatment – Antiviral Drugs.mp4 |
44.01MB |
| 04.14 Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs.mp4 |
11.88MB |
| 04.15 Case Study – Antiviral Drugs.mp4 |
41.60MB |
| 04. Androgens and Antiandrogens.mp4 |
40.67MB |
| 04. COX-2 Inhibitors.mp4 |
15.69MB |
| 04. Leukotriene Receptor Antagonists.mp4 |
11.40MB |
| 04. Motility Disorder Medication.mp4 |
53.93MB |
| 04. Thrombolytics and Procoagulants.mp4 |
39.01MB |
| 05.01 Antimalarial Drugs – Antiprotozoal Agents.mp4 |
88.71MB |
| 05.01 Overview – Anti-Seizure Medications.mp4 |
25.37MB |
| 05.02 Amebicides – Antiprotozoal Agents.mp4 |
58.22MB |
| 05.02 Treatment Strategies – Anti-Seizure Medications.mp4 |
65.55MB |
| 05.03 Nematicides – Antihelmintic Drugs.mp4 |
36.54MB |
| 05.03 Questions – Anti-Seizure Medications.mp4 |
22.01MB |
| 05.04 Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Antihelmintic Drugs.mp4 |
15.42MB |
| 05.05 Questions – Antiprotozoal and Antihelmintic Drugs.mp4 |
20.58MB |
| 05. Anti-Inflammatory Agents Release Inhibitors and IgE-Antibodies.mp4 |
12.96MB |
| 05. Disease Modifying Anti Rheumatic Agents (DMARDS).mp4 |
44.98MB |
| 05. Nausea Medication Antiemetics – Gastrointestinal Drugs.mp4 |
40.63MB |
| 05. Questions and Case Studies – Reproductive Pharmacology.mp4 |
20.81MB |
| 05. Questions Coagulant Drugs.mp4 |
21.55MB |
| 06.01 Overview – Anesthetic Drugs.mp4 |
4.94MB |
| 06.02 Inhaled Anesthetics – Anesthetic Drugs.mp4 |
30.42MB |
| 06.03 General Anesthetics – Anesthetic Drugs.mp4 |
41.59MB |
| 06.04 Intravenous Anesthetics – Anesthetic Drugs.mp4 |
24.45MB |
| 06.05 Case Study – Anesthetic Drugs.mp4 |
21.78MB |
| 06. Asthma Medication Questions.mp4 |
16.18MB |
| 06. Gout Medication Colchicine, Uric Acid and More.mp4 |
42.54MB |
| 06. Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs.mp4 |
16.88MB |
| 07.01 Overview – Skeletal Muscle Relaxants.mp4 |
8.69MB |
| 07.02 Neuromuscular Blockers – Skeletal Muscle Relaxants.mp4 |
34.55MB |
| 07.03 Acute and Chronic Muscle Spasms – Skeletal Muscle Relaxants.mp4 |
33.21MB |
| 07.04 Questions – Skeletal Muscle Relaxants.mp4 |
34.64MB |
| 07. Inflammation Pharmacology Questions.mp4 |
27.30MB |
| 07. Irritable Bowel Syndrome (IBS) Medication.mp4 |
16.89MB |
| 08.01 Overview – Local Anesthetics.mp4 |
39.75MB |
| 08.02 Esters and Amides – Local Anesthetics.mp4 |
32.95MB |
| 08.03 Overview – Opioid Analgesics.mp4 |
15.11MB |
| 08.04 Opioid Agonists – Opioid Analgesics.mp4 |
32.95MB |
| 08.05 Mixed AgonistsAntagonists and Antagonists – Opioid Analgesics.mp4 |
31.52MB |
| 08.06 Questions – Local Anesthetics and Opioid Analgesics.mp4 |
32.84MB |
| 08. Questions and Case Studies H2 Blockers, GERD Medication and Domperidone.mp4 |
18.88MB |
| Slides 01.pdf |
1.98MB |
| Slides 02.pdf |
1.31MB |
| Slides 03.pdf |
425.51KB |